Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delafloxacin vs Ceftriaxone in Uncomplicated Urogenital Gonorrhea
NCT02015637Phase 3Terminated
- Sponsor
- Melinta Therapeutics
- Start
- Jan 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of delafloxacin in gonorrhea, sponsored by Melinta Therapeutics. Started Jan 2014; status: terminated.
02
Drugs
delafloxacin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT02015637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015637.